Vancouver, BC, August 8, 2014 - Supreme Pharmaceuticals` (CSE:SL) President & CEO, David Stadnyk and Head of Operations, John Fowler discuss the company`s history and its entry into the Medical Marijuana field in a recent presentation at the GreenRush Financial Conference in Toronto, Canada.

In April, the company moved from the TSX Venture Exchange to the Canadian Securities Exchange in order to efficiently and seamlessly transition from a junior resource company to one whose main focus is now on the emerging medical marijuana field.

The video presentation is now available for viewing. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Supreme" in the search box.

Supreme has operations in British Columbia and Ontario, Canada, where construction at Supreme Pharmaceutical`s Southern Ontario facility is progressing efficiently and the company anticipates inviting both Health Canada and the RCMP for final security inspection in early fall. Subsequent to a successful inspection, of which there is no guarantee, the company will receive final receipt of the commercial Marihuana for Medical Purposes Regulations license.

The company recently announced plans to use Arizona as a launch pad to enter the US market and evaluate additional acquisitions in states such as Nevada, Florida and others as they open the doors to medicinal and recreational cannabis. These opportunities include, but are not limited to, edibles, cultivation, and dispensary operations.

Arizona, one of 23 states where marijuana is now legal for medical use, had 52,731 licensed users as at June 30, 2014, with approximately 71% using marijuana for the treatment of chronic pain. .

With full legalization heading to the ballot in Alaska and Oregon, the size of the noncriminal marijuana industry is expected to continue to grow.

The shares are currently trading at $0.31, and with 58.6 million shares outstanding, the company is capitalized at $18.2 million.

For more information, please visit the company`s website, www.supremepharmaceuticals.com, call 604-674-2191 or email info@supremepharmaceuticals.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com